C. L. Ogden, M. D. Carroll, L. R. Curtin, M. A. McDo-well, C. J. Tabak and K. M. Flegal, “Prevalence of Overweight and Obesity in the United States, 1999-2004,” JAMA, Vol. 295, No. 13, 2006, pp. 1549-1555.
 H. Kolb and T. Mandrup-Poulsen, “The Global Diabetes Epidemic as a Consequence of Lifestyle-Induced Low-Grade Inflammation,” Diabetologia, Vol. 53, No. 1, 2010, pp. 10-20. http://dx.doi.org/10.1007/s00125-009-1573-7
 R. H. Unger, “Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome,” Endocrinology, Vol. 144, No. 12, 2003, pp. 5159-5165. http://dx.doi.org/10.1210/en.2003-0870
 A. Gastaldelli, E. Ferrannini, Y. Miyazaki, M. Matsuda and R. A. DeFronzo, “San Antonio Metabolism Study. Beta-Cell Dysfunction and Glucose Intolerance: Results from the San Antonio Metabolism (SAM) Study,” Diabetología, Vol. 47, No. 1, 2004, pp. 31-39.
 G. Schernthaner, J. M. Brix, H. P. Kopp and G. H. Schernthaner, “Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010,” Diabetes Care, Vol. 34, No. 2, 2010, pp. 355S-360S.
 W. J. Pories, K. G. MacDonald Jr., E. J. Morgan, M. K. Sinha, G. L. Dohm, M. S. Swanson, et al., “Surgical Treatment of Obesity and Its Effect on Diabetes: 10-y Follow-Up,” The American Journal of Clinical Nutrition, Vol. 55, No. 2, 1992, pp. 582S-85S.
 C. D. Sjostrom, L. Lissner, H. Wedel and L. Sjostrom, “Reduction in Incidence of Diabetes, Hypertension and Lipid Disturbances after Intentional Weight Loss induced by Bariatric Surgery: The SOS Intervention Study,” Obesity Research, Vol. 7, No. 5, 1999, pp. 477-484.
 L. Sjostrom, A. K. Lindroos, M. Peltonen, J. Torgerson, C. Bouchard, B. Carlsson, et al., “Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery,” New England Journal of Medicine, Vol. 351, No. 26, 2004, pp. 2683-2693.
 W. J. Pories, “Bariatric Surgery: Risks and Rewards,” Journal of Clinical Endocrinology & Metabolism, Vol. 93, No. 11, 2008, pp. S89-S96.
 D. R. Cottam, S. G. Mattar, E. Barinas-Mitchell, et al., “The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss,” Obesity Surgery, Vol. 14, No. 15, 2004, pp. 589-600.
 N. Scopinaro, F. Papadia, G. Camerini, G. Marinari, D. Civalleri and A. Gian Franco, “A Comparison of a Personal Series of Biliopancreatic Diversion and Literature Data on Gastric Bypass Help to Explain the Mechanisms of Resolution of Type 2 Diabetes by the Two Operations,” Obesity Surgery, Vol. 18, No. 8, 2008, pp. 1035-1038.
 D. S. Hess, D. W. Hess and R. S. Oakley, “The Biliopancreatic Diversion with the Duodenal Switch: Results beyond 10 Years,” Obesity Surgery, Vol. 15, No. 3, 2005, pp. 408-416.
 A. C. Wittgrove and G. W. Clark, “Laparoscopic Gastric Bypass, Roux-en-Y-500 Patients: Technique and Results, with 3 -60 Month Follow-Up,” Obesity Surgery, Vol. 10, No. 3, 2000, pp. 233-239.
 J. J. Arrizabalaga, A. Calanas-Continente, J. Vidal, et al., “Guía Práctica Clínica Para el Manejo del Sobrepeso y la Obesidad en Personas Adultas,” Endocnologia y Nutrición, Vol. 50, Suppl. 4, 2003, pp. 1-38.
 H. Buchwald, Y. Avidor, E. Braunwald, M. D. Jensen, W. Pories, K. Fahrbach, et al., “Bariatric Surgery: A Systematic Review and Meta-Analysis,” JAMA, Vol. 292, No. 14, 2004, pp. 1724-1737.
 L. Sjostrom, K. Narbro, C. D. Sjostrom, K. Karason, B. Larsson, H. Wedel, et al., “Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects,” New England Journal of Medicine, Vol. 357, No. 8, 2007, pp. 741-752.
 P. R. Schauer, B. Burguera, S. Ikramuddin, D. Cottam, W. Gourash, G. Hamad, et al., “Effect of Laparoscopic Rouxen Y Gastric Bypass on Type 2 Diabetes Mellitus,” Annals of Surgery, Vol. 238, No. 4, 2003, pp. 467-484.
 J. A. Tadross and C. W. le Roux, “The Mechanisms of Weight Loss after Bariatric Surgery,” International Journal of Obesity (London), Vol. 33, Suppl. 1, 2009, pp. S28-S32. http://dx.doi.org/10.1038/ijo.2009.14
 D. E. Cummings, J. Overduin and K. E. Foster-Schubert, “Gastric Bypass for Obesity: Mechanisms of Weight Loss and Diabetes Resolution,” Journal of Clinical Endocrinology & Metabolism, Vol. 89, No. 6, 2004, pp. 2608-2615. http://dx.doi.org/10.1210/jc.2004-0433
 D. S. Tichansky, J. D. Boughter Jr. and A. K. Madan, “Taste Change after Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Gastric Banding,” Surgery for Obesity and Related Diseases, Vol. 2, No. 4, 2006, pp. 440-444.
 D. E. Cummings, D. S. Weigle, R. S. Frayo, P. A. Breen, M. K. Ma, E. P. Dellinger, et al., “Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery,” New England Journal of Medicine, Vol. 346, No. 21, 2002, pp. 1623-1630.
 J. Korner, M. Bessler, L. J. Cirilo, I. M. Conwell, A. Daud, N. L. Restuccia, et al., “Effects of Roux-en-Y Gastric Bypass Surgery on Fasting and Postprandial Concentrations of Plasma Ghrelin, Peptide YY, and Insulin,” Journal of Clinical Endocrinology & Metabolism, Vol. 90, No. 1, 2005, pp. 359-365.
 W. J. Pories, M. S. Swanson, K. G. MacDonald, S. B. Long, P. G. Morris, B. M. Brown, et al., “Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus,” Annals of Surgery, Vol. 222, No. 3, 1995, pp. 339-350.
 D. E. Cummings, “Endocrine Mechanisms Mediating Remission of Diabetes after Gastric Bypass Surgery,” International Journal of Obesity (London), Vol. 33, Suppl. 1, 2009, pp. S33-S40.
 M. Hempen, H. P. Kopp, M. Elhenicky, et al., “YKL-40 Is Elevated in Morbidly Obese Patients and Declines after Weight Loss,” Obesity Surgery, Vol. 19, No. 11, 2009, pp. 1557-1563. http://dx.doi.org/10.1007/s11695-009-9917-4
 C. W. le Roux, S. J. Aylwin, R. L. Batterham, C. M. Borg, F. Coyle, V. Prasad, et al., “Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters,” Annals of Surgery, Vol. 243, No. 1, 2006, pp. 108-114.
 J. Korner, M. Bessler, W. Inabnet, C. Taveras and J. J. Holst, “Exaggerated Glucagon-Like Peptide-1 and Blunted Glucose-Dependent Insulinotropic Peptide Secretion Are Associated with Roux-en-Y Gastric Bypass but Not Adjustable Gastric Banding,” Surgery for Obesity and Related Diseases, Vol. 3, No. 6, 2007, pp. 597-601.
 J. M. Isbell, R. A. Tamboli, E. N. Hansen, et al., “The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity Following Roux-en-Y Gastric Bypass Surgery,” Diabetes Care, Vol. 33, No. 7, 2010, pp. 1438-1442. http://dx.doi.org/10.2337/dc09-2107
 F. Rubino, A. Forgione, D. E. Cummings, M. Vix, D. Gnuli, G. Mingrone, et al., “The Mechanism of Diabetes Control after Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes,” Annals of Surgery, Vol. 244, No. 5, 2006, pp. 741-749.
 M. J. Perley and D. M. Kipnis, “Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Sujbjects,” Journal of Clinical Investigation, Vol. 46, No. 12, 1967, pp. 1954-1962.
 M. Nauck, F. Stockmann, R. Ebert and W. Creutzfeldt, “Reduced Incretin Effect in Type 2 (Non-Insulin-Dependent) Diabetes,” Diabetologia, Vol. 29, No. 1, 1986, pp. 46-52. http://dx.doi.org/10.1007/BF02427280
 M. A. Nauck, N. Kleine, C. Orskov, J. J. Holst, B. Willms and W. Creutzfeldt, “Normalization of Fasting Hyperglycaemia by Exogenous Glucagon-Like Peptide 1 (7-36 Amide) in Type 2 (Non-Insulin-Dependent) Diabetic Patients,” Diabetologia, Vol. 36, No. 8, 1993, pp. 741-744.
 C. Guidone, M. Manco, E. Valera-Mora, A. Iaconelli, D. Gniuli, A. Mari, et al., “Mechanisms of Recovery from Type 2 Diabetes after Malabsorptive Bariatric Surgery,” Diabetes, Vol. 55, No. 7, 2006, pp. 2025-2031.
 D. J. Pournaras, A. Osborne, S. C. Hawkins, et al., “The Gut Hormone Response Following Roux-em-Y Gastric Bypass: Cross-Sectional and Prospective Study,” Obesity Surgery, Vol. 20, No. 1, 2010, pp. 56-60.
 T. D. Adams, A. M. Stroup, R. E. Gress, et al., “Cancer Incidence and Mortality after Gastric Bypass Surgery,” Obesity, Vol. 17, No. 4, 2009, pp. 796-802.